Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma von Petrini, Iacopo, Lencioni, Monica, Ricasoli, Miriam, Iannopollo, Mauro, Orlandini, Cinzia, Oliveri, Filippo, Bartolozzi, Carlo, Ricci, Sergio

Volltext

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the mo... von Barni, Sandro, Maiello, Evaristo, Di Maio, Massimo, Ardizzoni, Andrea, Cappuzzo, Federico, Maranzano, Ernesto, Novello, Silvia, Bennati, Chiara, Ori, Alessandra, Rizzoli, Sara, Crinò, Lucio

Volltext

Impact of IVS14+1G>A and 2846A>T DPYD polymorphisms on toxicity outcome of patients treated with fluoropyrimidine-containing regimens von Del Re, Marzia, Loupakis, Fotios, Barbara, Cecilia, Latiano, Tiziana, Vasile, Enrico, Zafarana, Elena, Cordio, Stefano Sergio, Toffolatti, Luisa, Ricasoli, Miriam, Prestifilippo, Angela, Venturini, Filippo, Di Donato, Samantha, Grifalchi, Federico, Rinaldi, Antonio, Butera, Alfredo, Maiello, Evaristo, Siena, Salvatore, Falcone, Alfredo, Cappuzzo, Federico, Danesi, Romano

Volltext

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy von Del Re, Marzia, Loupakis, Fotios, Barbara, Cecilia, Lombardo, Laura, Latiano, Tiziana, Zafarana, Elena, Cordio, Stefano, Toffolatti, Luisa, Ricasoli, Miriam, Giuffrida, Dario, Vanoli, Jennifer, Di Donato, Samantha, Grifalchi, Federico, Rinaldi, Antonio, Butera, Alfredo, Maiello, Evaristo, Siena, Salvatore, Brandes, Alba, Falcone, Alfredo, Cappuzzo, Federico, Danesi, Romano

Volltext